-
RTI International and Navidence Partner to Solve a Persistent Gap in Real-World Evidence: Standardizing How Diseases, Treatments and Outcomes Are Defined
Strategic investment brings together RTI’s scientific leadership and Navidence AI-native platform to improve research quality, reproducibility, and patient outcomes across the life sciences RESEARCH TRIANGLE PARK, N.C., May 5, 2026 /PRNewswire/ — Independent scientific research institute RTI
-
Mel-Mont Medical Recognized at ASCCP with the Best Innovative Technology in HPV mRNA-Based Cervical Cancer Triage
Recognition highlights growing momentum toward more accessible, patient-centered screening and type specific risk assessment after a positive HPV result DORAL, Fla., May 5, 2026 /PRNewswire/ — Mel-Mont Medical, a women’s health diagnostics company advancing accessible cervical cancer
-
SuperTruth Launches Sean’s Friends Donor Advised Fund and Commits That the Company Will Never Profit From Children
Founding tenet, not future arm. First grant directs proceeds to Children’s Hospital of Philadelphia; all future SuperTruth revenue from pediatric work to flow back into the fund. PHILADELPHIA, May 1, 2026 /PRNewswire/ — SuperTruth, the healthcare
-
Researchers from Incheon National University Spotlight Next-Generation EV Diagnostics
A new generation of single-vesicle tools enables earlier diagnosis, sharper disease tracking, and more personalized treatment decisions INCHEON, South Korea, May 1, 2026 /PRNewswire/ — Researchers at Incheon National University have reviewed emerging technologies that analyze
-
Advancing Cancer Care: Moffitt Cancer Center Selects Dicom Systems for Digital Pathology Infrastructure
DANVILLE, Calif., April 30, 2026 /PRNewswire/ — Dicom Systems, a leader in enterprise imaging workflow orchestration and interoperability, announced today that it will partner with Moffitt Cancer Center to support and scale its digital pathology
-
CounterX Therapeutics Invited to Present at Science2Startup
SEATTLE, April 29, 2026 /PRNewswire/ — CounterX Therapeutics today announced that the company has been selected to present at Science2Startup (S2S) in Cambridge, MA on May 13, 2026. Shawn Iadonato, Chief Executive Officer of CounterX
-
Coalition of Veterinarians, Scientists, and Health Care Professionals Launches the “Save Science Oregon” Campaign to Prevent Closure of the Oregon National Primate Research Center (ONPRC)
BEAVERTON, Ore., April 29, 2026 /PRNewswire/ — Oregon Voices for Biomedical Research (OVBR), a nonprofit advocacy group of veterinarians, scientists, healthcare professionals and concerned Oregonians, is launching a campaign to protect the Oregon National Primate Research Center (ONPRC) from closure. The campaign begins this week
-
Health AI Has Been Trained on Unscored Data. SuperTruth Just Published the Standard That Fixes It.
The Data Trust Index™ scores every health record across eight dimensions before it reaches a model, a claim, or a clinical decision. Validated on 105,000 records with imaware. Now available on Zenodo. PHILADELPHIA, April 27,
-
O’Shaughnessy Ventures Backs Scientist Decoding Biology’s Hidden Communication System
Shiwei Mitchell-Wang awarded an O’Shaughnessy Fellowship to map the molecular role of complex carbohydrates in human health and disease GREENWICH, Conn., April 24, 2026 /PRNewswire/ — O’Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators,
-
$500,000 Michael F. Price Memorial Grant from DeGregorio Family Foundation Awarded for Novel Gastroesophageal Cancer Therapy
NEW YORK, April 22, 2026 /PRNewswire/ — The DeGregorio Family Foundation with support from the Torrey Coast Foundation has awarded $250,000 to Timothy C. Wang, MD, Chief, Division of Digestive and Liver Diseases, Silberberg Professor of Medicine,